Latest 10-K annual reports

BlackBerry Limited announces its fiscal year 2025 results, highlighting a net loss of $79.0 million and providing revenue guidance for fiscal year 2026.

Tevogen Bio Holdings Inc. details its financial standing, development strategy, and regulatory landscape in its annual 10-K filing, emphasizing its ExacTcell technology and lead product candidate, TVGN 489.

NovaBay Pharmaceuticals is evaluating strategic options, including a potential dissolution, after selling its Avenova and wound care assets.

Cyclacel Pharmaceuticals' 2024 10-K filing reveals a company in strategic transition, focusing on its plogosertib program while addressing financial constraints through cost reductions and exploring strategic alternatives.

Dawson Geophysical reports a net loss for 2024 but highlights improved margins and strategic cost management amid fluctuating oil and gas prices.

RH's 10-K filing details the company's capital stock structure, shareholder rights, and provisions designed to deter hostile takeovers.

Serve Robotics files an amendment to its original 10-K report to include management's report on internal control over financial reporting, which was inadvertently omitted.

Buckle Inc.'s fiscal year 2024 saw a decrease in net sales, though the company continues to invest in store remodels and technology.

Elite Health Systems Inc. is concentrating on developing Medicare Advantage plans in California and Nevada, despite reporting a net loss of $2.055 million in 2024 and facing substantial doubt about its ability to continue as a going concern.

Luduson G Inc. reports a substantial net income of $12.4 million for 2024, marking a turnaround driven by revenue generation and strategic initiatives, while also acknowledging ongoing risks and uncertainties.

Lithium Corporation reports a net loss for fiscal year 2024 while continuing to focus on exploration and project generation in Nevada and British Columbia.

TJX Companies announces a 4% increase in net sales and diluted earnings per share of $4.26 for fiscal year 2025, alongside strategic global expansion initiatives.

Chilean Cobalt Corp.'s 10-K filing highlights its focus on the La Cobaltera cobalt-copper project in Chile, while acknowledging substantial doubt about its ability to continue as a going concern due to recurring losses.

Sportsman's Warehouse reports a decrease in net sales and a net loss for fiscal year 2024, impacted by consumer inflationary pressures and recession concerns, while focusing on cost reduction and strategic investments.

reAlpha Tech Corp. shifts focus to AI-driven homebuying platform after discontinuing short-term rental operations, reporting a net loss of $25.8 million for 2024.

Denali Capital Acquisition Corp.'s annual report reveals substantial doubt about its ability to continue as a going concern, despite efforts to merge with Semnur Pharmaceuticals.

Newsmax Inc.'s amended 10-K reveals a year of revenue growth driven by broadcasting and digital expansion, alongside strategic shifts in distribution and a settlement in a defamation lawsuit.

Nabors Energy Transition Corp. II files an amendment to its 2024 Form 10-K to include the conformed signature of WithumSmith+Brown, PC in the Audit Report.

Constellation Acquisition Corp I's recent 10-K filing reveals substantial doubt about its ability to continue as a going concern due to a working capital deficit and an approaching mandatory liquidation date.

ServiceTitan's 10-K filing for fiscal year 2025 showcases revenue growth driven by its platform and strategic initiatives, despite ongoing net losses and significant investments in technology and expansion.

CalEthos is developing a large-scale, geothermal-powered data center campus in Southern California, aiming to lease powered building lots and buildings to enterprise IT companies.

Worlds Inc. reports a net loss of $511,382 for the year ended December 31, 2024, as it focuses on monetizing its intellectual property and legacy virtual reality assets.

FiscalNote Holdings divests Oxford Analytica and Dragonfly to streamline operations and strengthen its financial position.

Entero Therapeutics' 10-K filing reveals significant operating losses and strategic realignments, raising substantial doubt about its ability to continue as a going concern.

Bayview Acquisition Corp's Form 10-K reveals substantial doubt about its ability to continue as a going concern, despite efforts to secure a business combination with Oabay Holding Company.

Sunshine Biopharma's 10-K filing reveals a revenue increase driven by expanded generic drug sales in Canada, but the company still reports a net loss for the year ended December 31, 2024.

Ooma's fiscal year 2025 saw an 8% increase in revenue, primarily driven by growth in the business segment and the acquisition of 2600Hz.

California BanCorp's 2024 results reflect the impact of its merger with California BanCorp (CALB), showing significant asset growth alongside increased expenses and strategic shifts.

Blue Dolphin Energy Company's 2024 10-K filing reveals a net loss, working capital challenges, and ongoing regulatory compliance issues, particularly concerning offshore asset decommissioning.

nCino's FY25 results highlight a strategic shift towards AI integration and platform expansion, with a focus on serving financial institutions globally.